Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ('Sigyn' or the 'Company') (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce.
Dear Reader,
Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on dialysis for survival in the United States. Additionally, Sigyn Therapy(TM) is able to target circulating factors underlying sepsis, a currently untreatable condition that is a leading cause of U.S. hospital deaths.
The U.S. Government has supported the development of blood purification therapies through the Defense Advanced Research Projects Agency (DARPA). If you're unfamiliar, the Economist Magazine describes DARPA as 'the agency that shaped the modern world,' having contributed to groundbreaking innovations such as GPS, drones, stealth technology, the personal computer, and even the internet.
DARPA Dialysis-Like Therapeutics Program
DARPA also has a long history of supporting breakthrough advances in medicine. In 2010, the agency launched a five-year program entitled Dialysis-Like Therapeutics (DLT) to advance blood purification technologies to treat bloodstream infections and sepsis.
Among the recipients of a DLT program contract was Aethlon Medical. As the founder of Aethlon, I oversaw development of the Hemopurifier(TM), a broad-spectrum virus clearance device that became the first blood purification technology to receive FDA Emergency-Use Authorization (EUA) to treat an emerging pandemic virus. In this case, Ebola virus, which occurred during the DLT program and under my leadership. Subsequently, blood purification therapies developed by two other members of the DARPA DLT team would be among the first therapies to receive EUA approval from FDA to treat COVID-19.
Note: As compared to the Hemopurifier(TM), we designed Sigyn Therapy(TM) with the intent to process the bloodstream more efficiently; to have a greater capacity to capture therapeutic targets; to addresses viral pathogens plus a wide range of inflammatory targets; and to improve scalability with lower production costs.
mRNA Vaccine Research Initiatives
Not long after the launch of its DLT program, DARPA initiated a rapid mRNA vaccine development program that would play pivotal role in the development of the Moderna COVID-19 vaccine.
When COVID-19 spread across the globe five years ago, the world faced an urgent need for a vaccine. At the time, the record for the fastest development of a vaccine to address a new virus was four years. In a groundbreaking achievement, mRNA-based vaccines from Moderna and Pfizer/BioNTech were available within a year of COVID-19 being declared a global health emergency by the World Health Organization. A study published in the journal The Lancet Infectious Diseases; estimated that these vaccines prevented between 14.4 to 19.8 million deaths worldwide in just their first year of distribution.
This unprecedented speed in vaccine development may have shifted the historic focus of post-exposure treatment countermeasures from single-target antiviral drugs to broad-spectrum blood purification technologies. Especially as preventative vaccines can be developed and distributed in a mere fraction of the time it takes to bring a post-exposure antiviral drug to market. Whereas blood purification therapies can be available at the outset of a viral outbreak.
Potential Advantages of Sigyn Therapy
As compared to a post-exposure antiviral drug, Sigyn Therapy(TM) offers several key advantages. Unlike antiviral drugs, our technology provides an expansive mechanism of action to reduce the circulating presence of viruses, toxins, inflammatory cytokines, and other deleterious factors from the bloodstream of infected individuals. While antiviral drugs can target a specific type of virus, Sigyn Therapy(TM) offers a broad-spectrum strategy to potentially address different strains, species, and families of viruses.
In closing, Sigyn Therapy(TM) is a candidate first-line countermeasures to address emerging viral threats. The continued convergence of global warming, urban crowding, and international travel will fuel new outbreaks. The question is not if, but how often these outbreaks will occur, how many lives will be lost, and what will be the global economic impact as emerging viral threats will not be constrained by borders.
In the meantime, the expansive mechanism of Sigyn Therapy(TM) allows for its potential dual use in everyday medicine. Our lead clinical opportunity incorporates Sigyn Therapy(TM) in series with regularly scheduled dialysis treatments to reduce endotoxemia and concurrent inflammation that contributes to shorten the lives of end-stage renal disease (ESRD) patients. Extending the lives of those suffering from ESRD could establish a strategic competitive advantage within the dialysis industry.
Thank you for taking the time to read my note.
Sincerely, Jim
About Sigyn Therapeutics(TM)
Sigyn Therapeutics is developing next-generation blood purification therapies to address life-threatening infectious disease disorders. Sigyn Therapy(TM) has been demonstrated to reduce the presence of viral pathogens, bacterial toxins, inflammatory cytokines, and other relevant therapeutic targets from human blood plasma. Based on these capabilities, Sigyn Therapy(TM) is a candidate to treat life-threatening viruses, endotoxemia, and sepsis, the leading cause of death in U.S. hospitals. The clinical protocol of first-in-human studies incorporates Sigyn Therapy into regularly scheduled dialysis treatments to address endotoxemia and concurrent inflammation, which are highly prevalent disorders that shorten the lives of end-stage renal disease (ESRD) patients. The value of extending ESRD patient lives is quantifiable based its potential impact on dialysis industry revenues.
The Company also has an oncology pipeline comprised of ImmunePrep(TM), a platform to enhance the delivery of immunotherapeutic antibodies; ChemoPrep(TM) to improve the delivery of chemotherapeutic agents; and ChemoPure(TM) to reduce chemotherapy toxicity. If successfully advanced, the Company's therapies offer to provide strategic value to the dialysis and biopharmaceutical industries.
Sigyn Therapeutics, Inc.
Johan Louw
Senior Vice President of Strategic Programs
281.660.1815
[email protected]
CEO, Inventor
Cautionary Note Regarding Forward-Looking Statements
This information in this press release contains forward-looking statements of Sigyn Therapeutics, Inc. ('Sigyn') that involve substantial risks and uncertainties. All statements contained in this summary are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as 'may,' 'believe,' 'anticipate,' 'expect,' 'intend,' 'plan,' 'project,' 'will,' 'projections,' 'estimate,' 'potentially' or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Sigyn's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors that may contribute to such differences may include, without limitation, the Company's ability to clinically advance Sigyn Therapy in human studies required for market clearance, the Company's ability to manufacture Sigyn Therapy, the Company's ability to raise capital resources, and other potential risks. The foregoing list of risks and uncertainties is illustrative but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption 'Risk Factors' in the Company's Annual Report on Form 10-K, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this report speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Shelter calls on KC community amidst nationwide mental illness surge
KANSAS CITY, Mo. — Mental health issues are on the rise across the United States, according to one Kansas City shelter. They say it's causing more people to experience homelessness, especially in Kansas City. A new report from Citygate Network shows that 31% of Shelter KC guests were unhoused for the first time. That same report showed that 62% of those people reported that they've struggled with mental illness, which is well above the 47% national average. 'I've seen the demographics get younger,' said James Kohoutek, the Associate Director at Shelter KC. 'I've seen the amount of first-time homelessness increase as well as chronic homelessness. So, it's a rough situation we have.' Kansas City police stop potential sideshow during First Friday; enforcement continues Kohoutek shared research that shows limited access to health care, family trauma and financial strain are all contributing factors to mental illness. According to him, many just need a safe space and the right resources to make progress. 'Someone who sits off to the side away from the group, and then they start to sit more towards the group, and then they start to participate in the group discussion and the group classes,' he said, speaking on the progress he's seen in some cases. 'They start to engage in mental health services, they engage with their recovery coach or counselor. And you just see them come alive in a beautiful way.' Now, the shelter is calling on the KC community to get involved to break the cycle. Whether it's through volunteering or simply learning more about the crisis, Shelter KC believes it'll take everyone to make lasting change. 'We all need people in our lives to help us move forward, whether you're on the streets or standing behind a news camera. We all need that healthy support,' Kohoutek echoed. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
8 hours ago
- Yahoo
Johnstown community walks to raise funds for cancer patients
JOHNSTOWN, Pa. (WTAJ) — Members of the Johnstown community participated in a walk to help cancer patients. The 10th annual Johnstown Walk of Hope saw over 30 groups of residents and cancer survivors take laps around Trojan Stadium at the Greater Johnstown High School. Basket raffle tables, along with a table of remembrance, where people lit candles to honor loved ones lost to cancer. 'Our mission is to help patients who are financially struggling to meet their bills,' Marlene Singer, the event coordinator, said. 'So if it's household bills or medical bills, travel and things like that, we're here to help them until they can get back on their feet again.' The walk featured a playground for kids, vendors and a moment to recognize the survivors with their own lap. Seeing people who have overcome cancer can give each patient strength to keep fighting. 'You hear a name and the word cancer in the same sentence. Probably the scariest moment of your life. So you need proof,' Rosie Zajdel-McKay, a cancer survivor, said. 'You need proof that it is survivable, and you just take each and every minute, every day, every moment that is granted to you from that time that you hear that.' The walk ended the morning with $76,000 donated for the cause. To donate, click the link here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
9 hours ago
- Yahoo
Mobile clinics aim to boost rural health care measles vaccinations amid outbreak
The "Wellness on Wheels" program launched in spring of 2024. (Courtesy of South Dakota Department of Health) The South Dakota Department of Health plans to send its fledgling mobile clinics to underserved and undervaccinated areas of the state in response to the nationwide measles outbreak making its way to the state. Last year, South Dakota reported its first measles case in nine years. The state Department of Health recently reported the state's first case this year in Meade County in western South Dakota. Last week, on Friday, a second case was reported in Rapid City. People who visited Sam's Club in that city on June 1, or Dakota Premier Medical Center the following day were urged by the department to monitor themselves for symptoms for 21 days. Measles is a highly contagious viral disease that spreads through the air. Those who lack immunity from vaccination or past infection are highly likely to catch it from an infected person. As surrounding states report more cases, Health Department Secretary Melissa Magstadt said the state's 'Wellness on Wheels' clinics can help encourage vaccinations. 'I question it myself': South Dakota vaccination rates fall amid mistrust and misinformation The fleet boasts five vehicles equipped to provide immunizations, test for sexually transmitted diseases such as syphilis, as well as provide screenings, prenatal care and other support. The effort fills in gaps to public health care access across the state, especially in rural and tribal communities, Magstadt said. 'It's about how we can actively use these tools to reach underserved populations,' Magstadt said. 'It's not something I would have thought about looking to leverage for something like measles vaccinations before.' The department hasn't decided where to send their fleet. Counties with the fewest kindergarteners vaccinated per capita for measles, mumps and rubella include Faulk, Jones and Hutchinson, state data shows. South Dakota counties that share tribal land and rural counties in south-central areas of the state rank the worst for clinical care use and access in the state, according to the University of Wisconsin Population Health Institute's 2023 report. Federal COVID relief funds paid for Wellness on Wheels. 'Because of the pandemic, public health infrastructure was found to be wanting,' Magstadt said. That infrastructure missed 'critical pieces' that hadn't been invested in, she said, such as health care access in rural areas. More than a hundred rural hospitals in the U.S. have closed in the last decade. The program, launched in April of last year, cost about $800,000 in federal funding. The state's public health COVID funding was also used to support a community health worker program, update emergency medical service equipment and telemedicine access, analyze the state of emergency medical services in South Dakota, and build a Public Health Lab and department training center. Magstadt said staff working with the Women, Infants and Children (WIC) program requested the mobile units. WIC is a federal-state program that provides healthy food, nutrition education and health care referrals to low-income women and their young children. So far, Wellness on Wheels staff have mainly driven to events. Magstadt said the department has focused on increasing awareness of the program and building trust in communities and among tribal leaders. She plans to have staff drive the buses to rural communities more regularly to increase exposure and encourage use. 'Being consistently at a facility or place every other week will help people find it,' Magstadt said. 'We talk about the importance of STI testing, for example, but if you don't know where to get tested then that's another barrier.' Magstadt plans to have the department park one of the vehicles at a homeless shelter in Rapid City this summer as well to encourage underserved urban communities to seek services. 'We like people to be connected to primary care services, but there are unique situations where it's harder to get to health care facilities,' Magstadt said. She compared the mobile clinics as a return to home visits by doctors. That practice largely ceased in the 1960s due to cost efficiencies. 'It's a part of this menu of health care access and options no longer requiring people to come to a clinic or health care system,' Magstadt said, 'but health care being taken to patients and families who need it.' Mobile health care clinics are available in every state. They range from public entities like South Dakota's Wellness on Wheels, to specialized, private care. Other mobile clinics operating in South Dakota, according to Mobile Health Map, include: Delta Dental Mobile Program Horizon Health on Wheels Midwest Street Medicine Mobile Women's Health Unit VA Mobile Counseling Program
